J9049 – Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9049
- Long description
- Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- Short description
- Inj, bortezomib, hospira
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2023
- Last change
- January 1, 2023 – No change
Frequently asked questions
What is HCPCS code J9049?
J9049 is a HCPCS Level II code for injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg.
Does Medicare cover J9049?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9041 – Injection, bortezomib, 0.1 mg
- J9042 – Injection, brentuximab vedotin, 1 mg
- J9043 – Injection, cabazitaxel, 1 mg
- J9044 – Injection, bortezomib, not otherwise specified, 0.1 mg
- J9045 – Injection, carboplatin, 50 mg
- J9046 – Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047 – Injection, carfilzomib, 1 mg
- J9048 – Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9050 – Injection, carmustine, 100 mg
- J9051 – Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052 – Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
- J9053 – Injection, belantamab mafodotin-blmf, 0.1 mg
- J9054 – Injection, bortezomib (boruzu), 0.1 mg
- J9055 – Injection, cetuximab, 10 mg
- J9056 – Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9057 – Injection, copanlisib, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.